levofloxacin-based regimens for treatment-resistant H. pylori infections

May 2006

Some experts are recommending levofloxacin-based regimens for treatment-resistant H. pylori infections.

Most patients get TRIPLE therapy with a proton pump inhibitor (PPI)...clarithromycin...and amoxicillin OR metronidazole.

If this doesn't work, the next choice is often QUADRUPLE therapy with bismuth...metronidazole...tetracycline...and a PPI.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

how to treat depression that just doesn't seem to go away
Women's Health Evista to prevent breast cancer
Women's Health whether VAGINAL estrogens are safe for women taking aromatase inhibitors
Women's Health OTC antiFUNGALS at the first sign of a problem even though most vaginal infections are actually BACTERIAL
confusion between Wellbutrin SR, Novo-Bupropion SR, and the new Wellbutrin XL
ADHD drug monographs will now include statements about the potential risk for sudden cardiac death
Obesity & Weight Loss the new diabetes drug, Byetta (exenatide), for weight loss
Ophthalmology Soft contact lens users are hearing warnings about serious fungal eye infections
Infectious Diseases Truvada (tenofovir/emtricitabine) BEFORE risky behaviour to prevent HIV infection
Cardiology Patients are asking if they should stop taking the combination of Plavix (clopidogrel) plus aspirin
Cardiology how to prevent or delay hypertension
Cardiology if chocolate is healthy
Gastroenterology Remicade (infliximab) is now the first biologic approved for ulcerative colitis
Gastroenterology levofloxacin-based regimens for treatment-resistant H. pylori infections
Medication Errors medication reconciliation
Supplements Health Canada has now approved sales of SAMe (S-adenosyl-L-methionine)
Practice Email and postal addresses are changing for some Regional Adverse Reaction Centres